Concepedia

Joachim Schuhmacher

JS

Statistics

Publications

13

Citations

926

H-Index

13

Active since

1995

Affiliations

Bayer (Germany)(Current)

Joachim Schuhmacher is an author at Bayer (Germany) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1995–2022

13

Publications

13

Matrix effects during analysis of plasma samples by electrospray and atmospheric pressure chemical ionization mass spectrometry: practical approaches to their elimination

Joachim Schuhmacher, Dieter Zimmer, Frank Tesche et al. · Rapid Communications in Mass Spectrometry · 2003 · 153 citations

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

Matthias Friedrich, Tobias Raum, Ralf Lutterbuese et al. · Molecular Cancer Therapeutics · 2012 · 142 citations

Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers

Urs B. Hagemann, Christine Ellingsen, Joachim Schuhmacher et al. · Clinical Cancer Research · 2019 · 106 citations

Determination of the Free Fraction and Relative Free Fraction of Drugs Strongly Bound to Plasma Proteins

Joachim Schuhmacher, K Bühner, Astrid Witt‐Laido · Journal of Pharmaceutical Sciences · 2000 · 77 citations

, , +11

Preclinical Efficacy of the Auristatin-Based Antibody–Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors

Anette Sommer, Charlotte Kopitz, Christoph A. Schatz et al. · Cancer Research · 2016 · 73 citations

, , +16

Rows per page

1–5 of 13